Decitabine immunosensitizes human gliomas to NY-ESO-1 specific T lymphocyte targeting through the Fas/Fas Ligand pathway

BACKGROUND: The lack of effective treatments for gliomas makes them a significant health problem and highlights the need for the development of novel and innovative treatment approaches. Immunotherapy is an appealing strategy because of the potential ability for immune cells to traffic to and destro...

Descripción completa

Detalles Bibliográficos
Autores principales: Konkankit, Veerauo V, Kim, Won, Koya, Richard C, Eskin, Ascia, Dam, Mai-Anh, Nelson, Stanley, Ribas, Antoni, Liau, Linda M, Prins, Robert M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3229551/
https://www.ncbi.nlm.nih.gov/pubmed/22060015
http://dx.doi.org/10.1186/1479-5876-9-192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3229551/
https://www.ncbi.nlm.nih.gov/pubmed/22060015
http://dx.doi.org/10.1186/1479-5876-9-192

Ejemplares similares